AUNA vs. THC: Which Ambulatory Care Stock Is the Smarter Bet Now?

Core Insights - Auna S.A. and Tenet Healthcare are prominent players in the ambulatory care sector, with Auna focusing on Latin America and Tenet on the U.S. market [1][15] Auna S.A. Overview - Auna operates a differentiated healthcare model in Spanish-speaking Latin America, addressing the fragmented private healthcare market [3] - In Peru, Auna's performance is bolstered by a strong pricing mix and a record low medical loss ratio, alongside a public-private partnership to expand its market [3][4] - The company is experiencing revenue recovery in Mexico, with a focus on expanding its reach to privately insured families and enhancing physician group alignment [4] - Auna is enhancing its oncology capabilities and implementing risk-sharing models in Colombia, which are yielding positive cash flow results [5] - Auna completed a $825 million debt refinancing, improving its capital structure and increasing cash position by 42% [6][7] Tenet Healthcare Overview - Tenet reported net operating revenues of $21.3 billion in 2025, a 14% increase from the previous year, with an adjusted EBITDA margin improvement of 200 basis points to 21.4% [8][12] - The company added 35 facilities to its portfolio in 2025, with a strong pipeline for M&A activity in 2026 [9] - Tenet's Hospital segment saw a 16% adjusted EBITDA growth, with new facility openings supporting capacity expansion [10] - The expiration of enhanced exchange tax credits is expected to impact Tenet's 2026 adjusted EBITDA, leading to lower volume growth [11] - Tenet held $2.88 billion in cash as of December 31, with a free cash flow of $2.53 billion and a leverage ratio of 2.25X EBITDA [12] Market Trends - The global ambulatory healthcare service market is projected to grow at a CAGR of 5.7% from 2026 to 2033, driven by increased demand for outpatient care and advancements in medical technology [2] - Auna's shares have increased by 7.4% year-to-date, while Tenet's shares have decreased by 5.4% [13] - Auna trades at a forward price/sales ratio of 0.31X, lower than its median, while Tenet trades at 0.75X, higher than its median [14] Conclusion - Both Auna S.A. and Tenet Healthcare are well-positioned to capitalize on industry trends, with Auna's strong performance in Peru and recovery in Mexico, and Tenet's steady performance across its segments [15][16] - Auna is currently viewed as the more compelling investment option based on valuation and performance metrics [16]